• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number H060040
Device Problem Material Protrusion/Extrusion (2979)
Patient Problem Aneurysm (1708)
Event Date 03/23/2020
Event Type  Injury  
Manufacturer Narrative
Patient identifier: no patient specific details have been provided.Therefore, the patient initials reflect the study number with codes for the hospital and patient.As the device remains implanted, no further investigation can be performed.Evaluation codes investigation findings c19 refers to the product history review: a review of the manufacturing- and heparin-coating records indicated the lot met all pre-release specifications.Neither images enabling direct assessment of product performance nor the product itself, which remains implanted, were returned for evaluation.The physician stated that the cause of bleeding was non-hemostasis of the graft puncture site and the cause of the pseudoaneurysm was bleeding from the graft puncture.In the instruction for use for the gore® propaten® vascular graft the following is stated: possible complications with the use of any vascular prosthesis complications which may occur in conjunction with the use of any vascular prosthesis include but are not limited to: excessive suture hole bleeding; formation of pseudoaneurysms due to excessive, localized, or large needle punctures heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
The following was reported to gore: on (b)(6) 2019, the patient underwent surgical treatment for the creation of a vascular access graft for hemodialysis with a gore® propaten® vascular graft.The device was implanted and retained.There were no adverse events during the procedure.It was dialyzed successfully through the graft on (b)(6) 2020.On (b)(6) 2020, a pseudoaneurysm was identified due to bleeding from a graft puncture and a secondary pseudoaneurysm, which required treatment.As reintervention a simple hemostatic graft suture with prolene in the device was performed the same day.The device patency was restored/maintained at the end of the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® PROPATEN® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key16002666
MDR Text Key305683585
Report Number2017233-2022-03584
Device Sequence Number1
Product Code DSY
Combination Product (y/n)Y
Reporter Country CodeSP
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial
Report Date 12/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/13/2023
Device Catalogue NumberH060040
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/23/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured06/14/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
Patient SexMale
-
-